Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-03

FDA Approved: AMLODIPINE AND VALSARTAN — Original Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved Alembic Pharmaceuticals' original application for a fixed-dose combination of amlodipine and valsartan, a generic hypertension medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMLODIPINE AND VALSARTAN (amlodipine and valsartan)

Snippet

ORIG AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)